Erik Abner

https://www.etis.ee/CV/Erik_Abner/eng
25.06.1986
53426365
erik.abner86@gmail.com
Languages:

Estonian - native
English - fluent
German - fluent
Spanish - good

Career

Institutions and positions
01.12.2019–...   
University of Tartu, Institute of Genomics, Research Fellow of Functional Genomics (1,00)
18.03.2019–30.11.2019   
University of Tartu, Institute of Genomics, Senior Specialist (1,00)
30.01.2017–12.06.2017   
Francis Crick Institute, Postdoctoral Training Fellow (1,00)
01.02.2012–10.01.2017   
Molecular Biology Institute of Barcelona, PhD Student (1,00)
 
 
Education
2012–2016   
Pompeu Fabra University, Biomedicine ; PhD
2010–2012   
Maastricht University, Clinical Molecular Sciences ; MSc
2005–2010   
Tallinn University of Technology, Gene Technology ; BSc

Qualifications

Academic degrees
Erik Abner, Doctor's Degree, 2016, (sup) Albert Jordan Vallès, Identification of HIV-1 reactivating quinoline compounds as bromodomain inhibitors, Pompeu Fabra University.
 
 
Honours & awards
2016, Erik Abner, Cum Laude, Biomedicine, Pompeu Fabra University (Barcelona), Spain
2016, Erik Abner, "International Doctor" mention in the Doctoral Diploma
 
 
Fields of research
ETIS CLASSIFICATION: 1. Biosciences and Environment; 1.2. Microbiology; CERCS CLASSIFICATION: B230 Microbiology, bacteriology, virology, mycology
ETIS CLASSIFICATION: 3. Health; 3.1. Biomedicine; CERCS CLASSIFICATION: B726 Clinical biology
 
 
Additional information
Visiting student during PhD program;
Harvard Medical School;
Supervisor: Monty Montano;
January 2016 - May 2016

Publications

Category
Year
Publication
 
1.1.
2019
Abner, Erik; Jordan, Albert (2019). HIV "shock and kill" therapy: In need of revision. Antiviral Research, 166, 19−34.10.1016/j.antiviral.2019.03.008.
1.1.
2019
Stoszko, Mateusz; Ne, Enrico; Abner, Erik; Mahmoudi, Tokameh (2019). A broad drug arsenal to attack a strenuous latent HIV reservoir. Current Opinion in Virology, 38, 37−53.10.1016/j.coviro.2019.06.001.
1.1.
2018
Abner, Erik; Stoszko, Mateusz; Zeng, Lei; Chen, Heng-Chang; Izquierdo-Bouldstridge, Andrea; Konuma, Tsuyoshi; Zorita, Eduard; Fanunza, Elisa; Zhang, Qiang; Mahmoudi, Tokameh; Zhou, Ming-Ming; Filion, Guillaume J.; Jordan, Albert (2018). A New Quinoline BRD4 Inhibitor Targets a Distinct Latent HIV-1 Reservoir for Reactivation from Other "Shock" Drugs. Journal of Virology, 92 (10), UNSP e02056-17.10.1128/JVI.02056-17.
12.12.2019

Erik Abner

https://www.etis.ee/CV/Erik_Abner/est
25.06.1986
53426365
erik.abner86@gmail.com
Keeled:
eesti keel - emakeel
inglise keel - väga hea
saksa keel - väga hea
hispaania keel - hea

Teenistuskäik

Töökohad ja ametid
01.12.2019–...   
Tartu Ülikool, Tartu Ülikooli genoomika instituut, funktsionaalse genoomika teadur (1,00)
18.03.2019–30.11.2019   
Tartu Ülikool, Tartu Ülikooli genoomika instituut, peaspetsialist (1,00)
30.01.2017–12.06.2017   
Francis Cricki Instituut, Järeldoktor (1,00)
01.02.2012–10.01.2017   
Molecular Biology Institute of Barcelona, Doktorant (1,00)
 
 
Haridustee
2012–2016   
Pompeu Fabra Ülikool, Biomedicine ; PhD
2010–2012   
Maastrichti Ülikool, Clinical Molecular Sciences ; MSc
2005–2010   
Tallinna Tehnikaülikool, Geenitehnoloogia ; BSc

Kvalifikatsioon

Teaduskraadid
Erik Abner, Doctor's Degree, 2016, (sup) Albert Jordan Vallès, Identification of HIV-1 reactivating quinoline compounds as bromodomain inhibitors, Pompeu Fabra University.
 
 
Teaduspreemiad ja tunnustused
2016, Erik Abner, Cum Laude, Biomeditsiin, Pompeu Fabra Ülikool (Barcelona), Hispaania
2016, Erik Abner, "International Doctor" äramärkimine doktorantuuri diplomis
 
 
Teadustöö põhisuunad
ETIS KLASSIFIKAATOR: 1. Bio- ja keskkonnateadused; 1.2. Mikrobioloogia; CERCS KLASSIFIKAATOR: B230 Mikrobioloogia, bakterioloogia, viroloogia, mükoloogia
ETIS KLASSIFIKAATOR: 3. Terviseuuringud; 3.1. Biomeditsiin; CERCS KLASSIFIKAATOR: B726 Kliiniline bioloogia
 
 
Lisainfo
Külalisdoktorant;
Harvard Medical School;
Juhendaja: Monty Montano;
Jaanuar 2016 - Mai 2016

Publikatsioonid

Klass
Aasta
Publikatsioon
 
1.1.
2019
Abner, Erik; Jordan, Albert (2019). HIV "shock and kill" therapy: In need of revision. Antiviral Research, 166, 19−34.10.1016/j.antiviral.2019.03.008.
1.1.
2019
Stoszko, Mateusz; Ne, Enrico; Abner, Erik; Mahmoudi, Tokameh (2019). A broad drug arsenal to attack a strenuous latent HIV reservoir. Current Opinion in Virology, 38, 37−53.10.1016/j.coviro.2019.06.001.
1.1.
2018
Abner, Erik; Stoszko, Mateusz; Zeng, Lei; Chen, Heng-Chang; Izquierdo-Bouldstridge, Andrea; Konuma, Tsuyoshi; Zorita, Eduard; Fanunza, Elisa; Zhang, Qiang; Mahmoudi, Tokameh; Zhou, Ming-Ming; Filion, Guillaume J.; Jordan, Albert (2018). A New Quinoline BRD4 Inhibitor Targets a Distinct Latent HIV-1 Reservoir for Reactivation from Other "Shock" Drugs. Journal of Virology, 92 (10), UNSP e02056-17.10.1128/JVI.02056-17.
12.12.2019
Advanced Search
  • Found 4 results
PublicationAuthorsYearEdition titleClassificationFileR&D institutions
A broad drug arsenal to attack a strenuous latent HIV reservoirStoszko, Mateusz; Ne, Enrico; Abner, Erik; Mahmoudi, Tokameh2019Current Opinion in Virology1.1.University of Tartu, Institute of Genomics
HIV "shock and kill" therapy: In need of revisionAbner, Erik; Jordan, Albert2019Antiviral Research1.1.
A New Quinoline BRD4 Inhibitor Targets a Distinct Latent HIV-1 Reservoir for Reactivation from Other "Shock" DrugsAbner, Erik; Stoszko, Mateusz; Zeng, Lei; Chen, Heng-Chang; Izquierdo-Bouldstridge, Andrea; Konuma, Tsuyoshi; Zorita, Eduard; Fanunza, Elisa; Zhang, Qiang; Mahmoudi, Tokameh; Zhou, Ming-Ming; Filion, Guillaume J.; Jordan, Albert2018Journal of Virology1.1.
P1-independent replication and local movement of Rice yellow mottle virus in host and non-host plant speciesNummert, G.; Sõmera, M.; Uffert, G.; Abner, E.; Truve, E.2017Virology1.1.Tallinn University of Technology , Faculty of Science, Department of Gene Technology, Chair of Gene Technology